Partners
MipSalus partners with leading research institutes, medical professionals, and others to develop its breakthrough treatment of Phenylketonuria (PKU).
Aarhus University, Denmark
Aarhus University Hospital, Denmark
Liverpool University, United Kingdom
Rigshospitalet, Denmark
Smerud Medical Research International, Norway
Innovation Fund Denmark
